From IP to IPO: Oxford Molecular Group Plc

OxFirst Board member Professor Graham Richards founded Oxford Molecular Ltd in 1989. It was the first spin-out from Oxford University in which the University had founder’s equity as a result of its owning the intellectual property following UK’s Prime Minister’s transfer of the ownership of government funded research to universities.

Our Contribution

The start-up company was funded by £350,000 of venture capital and operated in the area of computer-aided drug discovery with customers being mostly major international pharmaceutical companies.

Impact

The company was floated on the London Stock Exchange in 1992, with a third of the company being sold for £10 million. Graham Richards was chairman. The company grew and did seven take overs in the USA reaching a market capitalisation of £450 million before being sold in two parts to the US companies Pharmacopeia and Millennium.

Get In Touch.

If you are interested in working together, send us an inquiry and we will get back to you as soon as we can!

Contact Us